1
|
Pargami HN, Siadat SD, Amiri V, Sheikhpour M. Antibiotic delivery evaluation against Mycobacterium fortuitum using nanofluids containing carbon nanotubes. BMC Microbiol 2022; 22:96. [PMID: 35410123 PMCID: PMC8996581 DOI: 10.1186/s12866-022-02523-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Accepted: 04/07/2022] [Indexed: 12/01/2022] Open
Abstract
Background Mycobacterium fortuitum (M. fortuitum) is a bacterium, which can cause infections in many anatomical regions of the body, including the skin, lymph nodes, and joints. This bacterium, which belongs to a group of bacteria known as nontuberculous mycobacteria, is regarded as an important nosocomial pathogen worldwide owing to its increasing antibiotic resistance. Recently, the antimicrobial effects of carbon nanotubes have been reported in numerous studies. These nanotubes can be very useful in drug delivery; besides, they exhibit unique properties against multidrug-resistant bacterial infections. This study aimed to investigate the antimicrobial effects of carboxyl-functionalized multi-walled carbon nanotubes (MWCNT-COOH) to reduce antibiotic resistance. Methods In this study, antibacterial effects of nanofluids containing functionalized MWCNTs at initial concentration of 2 mg/mL and serial dilutions of 54, 28.5, 14.25, 7.12, 3.5 µg/mL, antibiotics alone and combination of nanofluids with antibiotics were investigated. Standard and resistant strains of M. fortuitum were obtained from the microbial bank of the Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran. Results It was observed that nanofluid containing MWCNT-COOH can exert antimicrobial effects on M. fortuitum and significantly reduce bacterial resistance to antibiotics including kanamycin and streptomycin. In the presence of antibiotics and nanofluids containing MWCNT-COOH at a dose of 28.5 µg/mL, no growth was observed. Conclusion One of the main antimicrobial mechanisms of MWCNT-COOH is penetration into the bacterial cell wall. In this study, by using the nanofluid containing MWCNT-COOH with increased stability, the antibiotic resistance of M. fortuitum was significantly reduced at lower dilutions compared to the antibiotic alone. Supplementary Information The online version contains supplementary material available at 10.1186/s12866-022-02523-z.
Collapse
Affiliation(s)
- Hamid Naderi Pargami
- Department of Biology, Faculty of Life Sciences, Danesh Alborz University, Abyek, Iran.,Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
| | - Seyed Davar Siadat
- Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.,Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran
| | - Vahid Amiri
- Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
| | - Mojgan Sheikhpour
- Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran. .,Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
| |
Collapse
|
2
|
Scheller J, Berg A, Moll JM, Floss DM, Jungesblut C. Current status and relevance of single nucleotide polymorphisms in IL-6-/IL-12-type cytokine receptors. Cytokine 2021; 148:155550. [PMID: 34217594 DOI: 10.1016/j.cyto.2021.155550] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2021] [Revised: 04/16/2021] [Accepted: 04/20/2021] [Indexed: 01/06/2023]
Abstract
Cytokines control immune related events and are critically involved in a plethora of patho-physiological processes including autoimmunity and cancer development. In rare cases, single nucleotide polymorphisms (SNPs) or single nucleotide variations (SNVs) in cytokine receptors eventually cause detrimental ligand-independent, constitutive activation of signal transduction. Most SNPs have, however, no or only marginal influences on gene expression, protein stability, localization and function and thereby only slightly affecting pathogenesis probability. The SNP database (dbSNP) is an archive for a broad collection of polymorphisms in which SNPs are categorized and marked with a locus accession number "reference SNP" (rs). Here, we engineered an algorithm to directly align dbSNP information to DNA and protein sequence information to clearly illustrate a genetic SNP landscape exemplified for all tall cytokine receptors of the IL-6/IL-12 family, including IL-23R, IL-12Rβ1, IL-12Rβ2, gp130, LIFR, OSMR and WSX-1. This information was complemented by a comprehensive literature summary and structural insights of relevant disease-causing SNPs in cytokine/cytokine receptor interfaces. In summary, we present a general strategy with potential to apply to other cytokine receptor networks.
Collapse
Affiliation(s)
- Jürgen Scheller
- Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
| | - Anna Berg
- Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
| | - Jens M Moll
- Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
| | - Doreen M Floss
- Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
| | | |
Collapse
|
3
|
Boisson-Dupuis S. The monogenic basis of human tuberculosis. Hum Genet 2020; 139:1001-1009. [PMID: 32055999 DOI: 10.1007/s00439-020-02126-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Accepted: 02/02/2020] [Indexed: 12/25/2022]
Abstract
The pathogenesis of tuberculosis (TB) remains poorly understood, as no more than 5-10% of individuals infected with Mycobacterium tuberculosis go on developing clinical disease. The contribution of human genetics to TB pathogenesis has been amply documented by means of classic genetics since the turn of the twentieth century. Over the last 20 years, following-up on the study of Mendelian susceptibility to mycobacterial disease (MSMD), monogenic disorders have been found to underlie TB in some patients. Rare inborn errors of immunity, such as autosomal recessive, complete IL-12Rβ1 and TYK2 deficiencies, impairing the IL-12- and IL-23-dependent induction of IFN-γ, were initially identified in a few patients. More recently, homozygosity for a common variant of TYK2 (P1104A) that selectively disrupts cellular responses to IL-23 was found in two cohorts of TB patients. It shows high penetrance in areas endemic for TB and appears to be responsible for about 1% of TB cases in populations of European descent. Both rare and common genetic etiologies of TB affect IFN-γ immunity, providing a rationale for novel preventive and therapeutic approaches for TB control, including the use of recombinant IFN-γ.
Collapse
Affiliation(s)
- Stephanie Boisson-Dupuis
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR1163, Paris, France. .,Paris Descartes University, Imagine Institute, Paris, France. .,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, New York, USA.
| |
Collapse
|
4
|
Chandra SR, Advani S, Kumar R, Prasad C, Pai AR. Factors Determining the Clinical Spectrum, Course and Response to Treatment, and Complications in Seronegative Patients with Central Nervous System Tuberculosis. J Neurosci Rural Pract 2019; 8:241-248. [PMID: 28479800 PMCID: PMC5402492 DOI: 10.4103/jnrp.jnrp_466_16] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
INTRODUCTION Tuberculous meningitis remains a major health issue in the community affecting young adults of both genders predominantly from rural background. In India, the disease continues to kill 2 people every 3 min or nearly 1000 daily, according to the Tuberculosis Control Society India. Tuberculosis (TB) of central nervous system (CNS) is the most devastating form of TB. As this disease is associated with very high prevalence in young adults and will ultimately contribute to great workforce loss, we decided to assess the factors deciding the disease and its course in our patients. PATIENTS AND METHODS Seronegative patients with probable CNS TB and attending our outpatient department were included and followed up for 2 years. RESULTS Low body mass index, low proteins, albumin, and low CD3 and CD4, pulmonary TB appears to be a common denominator in a vast majority of these patients. Delay in diagnosis and hyponatremia contributes to morbidity. The location of exudates causes morbidity when they are seen in optochiasmal region. Bacille Calmette-Guerin (BCG) vaccination status in the community appears to be very small. CONCLUSION CNS TB causes considerable morbidity and mortality in rural young adults resulting in severe manpower loss. Awareness into the possible role of BCG in reducing the complications of TB, role of nutrition and immunity even in seronegative patients and high-degree suspicion in medical professionals can bring down the burden of this deadly disease in the society.
Collapse
Affiliation(s)
| | - Sikandar Advani
- Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
| | - Ravi Kumar
- Department of Neuromicrobiology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
| | - Chandrajith Prasad
- Department of Neuroradiology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
| | - Anupama R Pai
- Department of Neuromicrobiology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
| |
Collapse
|
5
|
Wang S, Li Y, Shen Y, Wu J, Gao Y, Zhang S, Shao L, Jin J, Zhang Y, Zhang W. Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB. J Transl Med 2018; 16:206. [PMID: 30029650 PMCID: PMC6054748 DOI: 10.1186/s12967-018-1572-x] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2018] [Accepted: 07/07/2018] [Indexed: 01/20/2023] Open
Abstract
BACKGROUND The early and accurate diagnosis of tuberculosis (TB) is critical for controlling the global TB epidemic. Although early studies have supported the potential role of cytokine biomarkers in blood for the diagnosis of TB, this method requires further investigation and validation in different populations. A set of biomarkers that can discriminate between active TB (ATB) and latent TB infection (LTBI) remains elusive. METHODS In the current study, we organized two retrospective cohorts and one prospective cohort to investigate the immune responses at different clinical stages of TB infection, as determined by candidate cytokine biomarkers detected with a multiplex cytokine platform. Using a pre-established diagnostic algorithm, participants were classified as ATB, LTBI, and TB uninfected controls (CON). Based on our multiplex cytokine assay, a multi-cytokine biosignature was modelled for the optimal recognition of the different TB infection status. RESULTS Our analysis identified a six-cytokine biosignature of TB-antigen stimulated IFN-γ, IP-10, and IL-1Ra, and unstimulated IP-10, VEGF, and IL-12 (p70) for a biomarker screening group (n = 88). The diagnostic performance of the biosignature was then validated using a biomarker validation cohort (n = 216) and resulted in a sensitivity of 88.2% and a specificity of 92.1%. In a prospectively recruited clinical validation cohort (n = 194), the six-cytokine biosignature was further evaluated, and displayed a sensitivity of 85.7%, a specificity of 91.3% and an overall accuracy of 88.7%. CONCLUSIONS We have identified a six-cytokine biosignature for accurately differentiating ATB patients from subjects with LTBI and CON. This approach holds promise as an early and rapid diagnostic test for ATB.
Collapse
Affiliation(s)
- Sen Wang
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China
| | - Yang Li
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China
| | - Yaojie Shen
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China
| | - Jing Wu
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China
| | - Yan Gao
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China
| | - Shu Zhang
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China
| | - Lingyun Shao
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China
| | - Jialin Jin
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China
| | - Ying Zhang
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.,Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.,MOH and MOE Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.,Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21205, USA
| | - Wenhong Zhang
- Department of Infectious Diseases, Institute of Infectious Diseases, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China. .,Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China. .,MOH and MOE Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
| |
Collapse
|
6
|
Abstract
Mycobacterium fortuitum is a rapidly growing Mycobacterium species that is a rare cause of disease, primarily in immunocompromised patients. We present a very low birth weight preterm neonate who developed M. fortuitum bloodstream infection, where 16S rDNA sequencing allowed accurate identification. Cure was achieved by line removal and adjuvant combination treatment with amikacin, ciprofloxacin and clarithromycin.
Collapse
|
7
|
Boisson-Dupuis S, Bustamante J, El-Baghdadi J, Camcioglu Y, Parvaneh N, El Azbaoui S, Agader A, Hassani A, El Hafidi N, Mrani NA, Jouhadi Z, Ailal F, Najib J, Reisli I, Zamani A, Yosunkaya S, Gulle-Girit S, Yildiran A, Cipe FE, Torun SH, Metin A, Atikan BY, Hatipoglu N, Aydogmus C, Kilic SS, Dogu F, Karaca N, Aksu G, Kutukculer N, Keser-Emiroglu M, Somer A, Tanir G, Aytekin C, Adimi P, Mahdaviani SA, Mamishi S, Bousfiha A, Sanal O, Mansouri D, Casanova JL, Abel L. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev 2015; 264:103-20. [PMID: 25703555 DOI: 10.1111/imr.12272] [Citation(s) in RCA: 138] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb) and a few related mycobacteria, is a devastating disease, killing more than a million individuals per year worldwide. However, its pathogenesis remains largely elusive, as only a small proportion of infected individuals develop clinical disease either during primary infection or during reactivation from latency or secondary infection. Subacute, hematogenous, and extrapulmonary disease tends to be more frequent in infants, children, and teenagers than in adults. Life-threatening primary TB of childhood can result from known acquired or inherited immunodeficiencies, although the vast majority of cases remain unexplained. We review here the conditions conferring a predisposition to childhood clinical diseases caused by mycobacteria, including not only M.tb but also weakly virulent mycobacteria, such as BCG vaccines and environmental mycobacteria. Infections with weakly virulent mycobacteria are much rarer than TB, but the inherited and acquired immunodeficiencies underlying these infections are much better known. Their study has also provided genetic and immunological insights into childhood TB, as illustrated by the discovery of single-gene inborn errors of IFN-γ immunity underlying severe cases of TB. Novel findings are expected from ongoing and future human genetic studies of childhood TB in countries that combine a high proportion of consanguineous marriages, a high incidence of TB, and an excellent clinical care, such as Iran, Morocco, and Turkey.
Collapse
Affiliation(s)
- Stéphanie Boisson-Dupuis
- St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, INSERM-U1163, Paris, France; Paris Descartes University, Imagine Institute, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M. Nontuberculous mycobacteria in Middle East: Current situation and future challenges. Int J Mycobacteriol 2015; 4:7-17. [PMID: 26655192 DOI: 10.1016/j.ijmyco.2014.12.005] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2014] [Revised: 12/07/2014] [Accepted: 12/16/2014] [Indexed: 11/30/2022] Open
Abstract
Nontuberculous mycobacteria (NTM) are a diverse group of bacterial species that are distributed in the environment. Many of these environmental bacteria can cause disease in humans. The identification of NTM in environmental sources is important for both clinical and epidemiological purposes. In this study, the distribution of NTM species from environmental and clinical samples in the Middle East was reviewed. In order to provide an overview of NTM, as well as recent epidemiological trends, all studies addressing NTM in the Middle East from 1984 to 2014 were reviewed. A total of 96 articles were found, in which 1751 NTM strains were isolated and 1084 of which were obtained from clinical samples, 619 from environmental samples and 48 were cited by case reports. Mycobacterium fortuitum was the most common rapid growing mycobacteria (RGM) isolated from both clinical (269 out of 447 RGM; 60.1%) and environmental (135 out of 289 RGM; 46.7%) samples. Mycobacterium avium complex (MAC) was the most common slow growing mycobacteria (SGM) isolated from clinical samples (140 out of 637 SGM; 21.9%). An increasing trend in NTM isolation from the Middle East was noted over the last 5years. This review demonstrates the increasing concern regarding NTM disease in the Middle East, emphasizing the need for regional collaboration and coordination in order to respond appropriately.
Collapse
Affiliation(s)
- Ali Akbar Velayati
- Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Sanaz Rahideh
- Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Zahra Derakhshani Nezhad
- Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Parissa Farnia
- Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Mehdi Mirsaeidi
- Division of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois at Chicago, USA.
| |
Collapse
|
9
|
Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol 2014; 26:454-70. [PMID: 25453225 DOI: 10.1016/j.smim.2014.09.008] [Citation(s) in RCA: 440] [Impact Index Per Article: 44.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/12/2014] [Revised: 09/28/2014] [Accepted: 09/29/2014] [Indexed: 12/20/2022]
Abstract
Mendelian susceptibility to mycobacterial disease (MSMD) is a rare condition characterized by predisposition to clinical disease caused by weakly virulent mycobacteria, such as BCG vaccines and environmental mycobacteria, in otherwise healthy individuals with no overt abnormalities in routine hematological and immunological tests. MSMD designation does not recapitulate all the clinical features, as patients are also prone to salmonellosis, candidiasis and tuberculosis, and more rarely to infections with other intramacrophagic bacteria, fungi, or parasites, and even, perhaps, a few viruses. Since 1996, nine MSMD-causing genes, including seven autosomal (IFNGR1, IFNGR2, STAT1, IL12B, IL12RB1, ISG15, and IRF8) and two X-linked (NEMO, and CYBB) genes have been discovered. The high level of allelic heterogeneity has already led to the definition of 18 different disorders. The nine gene products are physiologically related, as all are involved in IFN-γ-dependent immunity. These disorders impair the production of (IL12B, IL12RB1, IRF8, ISG15, NEMO) or the response to (IFNGR1, IFNGR2, STAT1, IRF8, CYBB) IFN-γ. These defects account for only about half the known MSMD cases. Patients with MSMD-causing genetic defects may display other infectious diseases, or even remain asymptomatic. Most of these inborn errors do not show complete clinical penetrance for the case-definition phenotype of MSMD. We review here the genetic, immunological, and clinical features of patients with inborn errors of IFN-γ-dependent immunity.
Collapse
Affiliation(s)
- Jacinta Bustamante
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, INSERM-U1163, Paris, France, EU; Paris Descartes University, Imagine Institute, Paris, France, EU; Center for the Study of Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris AP-HP, Necker-Enfants Malades Hospital, Paris, France, EU.
| | - Stéphanie Boisson-Dupuis
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, INSERM-U1163, Paris, France, EU; Paris Descartes University, Imagine Institute, Paris, France, EU; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
| | - Laurent Abel
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, INSERM-U1163, Paris, France, EU; Paris Descartes University, Imagine Institute, Paris, France, EU; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
| | - Jean-Laurent Casanova
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, INSERM-U1163, Paris, France, EU; Paris Descartes University, Imagine Institute, Paris, France, EU; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA; Howard Hughes Medical Institute, NY, USA; Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children, Paris, France, EU
| |
Collapse
|
10
|
Chowdhury IH, Ahmed AM, Choudhuri S, Sen A, Hazra A, Pal NK, Bhattacharya B, Bahar B. Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy. Mol Immunol 2014; 62:159-68. [PMID: 25019566 DOI: 10.1016/j.molimm.2014.06.002] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2014] [Revised: 05/30/2014] [Accepted: 06/03/2014] [Indexed: 11/29/2022]
Abstract
Active pulmonary tuberculosis (APTB) is associated with a failure of the host immune system to control the invading Mycobacterium tuberculosis (Mtb). The objective of this study was to quantify and assess the role of serum inflammatory cytokines in active pulmonary tuberculosis patients following anti-tuberculosis drug (ATD) therapy. Blood samples were collected from APTB patients and normal healthy subjects (NHS) (total n=204) at baseline and 2, 4 and 6 months post-therapy and the abundance of serum inflammatory cytokines were measured by cytokine specific ELISA. Compared to NHS, APTB patients at baseline had higher levels of serum pro-inflammatory cytokines IL-12p40 (P<0.001), IFN-γ (P<0.001), TNF-α (P<0.01), IL-1β (P<0.001) and IL-6 (P<0.001) and anti-inflammatory cytokines IL-10 (P<0.001) and TGF-β1 (P<0.001) while there was no change in the level of IL-4. In APTB patients, the serum levels of IFN-γ, TNF-α, IL-6 and TGF-β1 directly relate to the bacterial load while the TNF-α, IL-1β, IL-6 and TGF-β1 relate to radiological severity. At baseline, the IL-6 level in NHS and APTB patients differed most and following ATD therapy, this level rapidly decreased and stabilized by 4-month in APTB patients. It is concluded that a subtle reduction in the serum level of IL-6 of the APTB patients following ATD therapy might play a vital role in immune-protection of the host against Mtb infection and hence the serum IL-6 level can be a useful marker to diagnose the effectiveness of therapy in the patients.
Collapse
Affiliation(s)
- Imran Hussain Chowdhury
- Department of Biochemistry, Institute of Postgraduate Medical Education and Research (IPGME&R), 244B, AJC Bose Road, Kolkata 700020, India
| | - Albin Mostaque Ahmed
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Dublin, Ireland
| | - Subhadip Choudhuri
- Department of Biochemistry, Institute of Postgraduate Medical Education and Research (IPGME&R), 244B, AJC Bose Road, Kolkata 700020, India
| | - Aditi Sen
- Department of Biochemistry, Institute of Postgraduate Medical Education and Research (IPGME&R), 244B, AJC Bose Road, Kolkata 700020, India
| | - Avijit Hazra
- Department of Pharmacology, Institute of Postgraduate Medical Education and Research (IPGME&R), 244B, AJC Bose Road, Kolkata 700020, India
| | - Nishith Kumar Pal
- Department of Microbiology, Institute of Postgraduate Medical Education and Research (IPGME&R), 244B, AJC Bose Road, Kolkata - 700020, India
| | - Basudev Bhattacharya
- Department of Biochemistry, Institute of Postgraduate Medical Education and Research (IPGME&R), 244B, AJC Bose Road, Kolkata 700020, India
| | - Bojlul Bahar
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Dublin, Ireland; School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Dublin, Ireland.
| |
Collapse
|
11
|
Different penetrance of disseminated infections caused by nontuberculous Mycobacteria in Mendelian susceptibility to mycobacterial disease associated with a novel mutation. Pediatr Infect Dis J 2014; 33:328-30. [PMID: 24064560 DOI: 10.1097/inf.0000000000000099] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Deficiency in the interleukin12/INFgamma pathway is a genetic condition that predisposes to some infections, including nontuberculous mycobacteria infection and extraintestinal salmonellosis. We report 2 cases in sisters who were diagnosed with a genetic defect caused by a new mutation in Interleukin-12 receptor β1 chain (IL12Rβ1) leading to different clinical presentations and responses to therapy.
Collapse
|
12
|
van de Vosse E, Haverkamp MH, Ramirez-Alejo N, Martinez-Gallo M, Blancas-Galicia L, Metin A, Garty BZ, Sun-Tan Ç, Broides A, de Paus RA, Keskin Ö, Çağdaş D, Tezcan I, Lopez-Ruzafa E, Aróstegui JI, Levy J, Espinosa-Rosales FJ, Sanal Ö, Santos-Argumedo L, Casanova JL, Boisson-Dupuis S, van Dissel JT, Bustamante J. IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database. Hum Mutat 2013; 34:1329-39. [PMID: 23864330 DOI: 10.1002/humu.22380] [Citation(s) in RCA: 69] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2013] [Accepted: 07/03/2013] [Indexed: 01/09/2023]
Abstract
IL-12Rβ1 deficiency is an autosomal recessive disorder characterized by predisposition to recurrent and/or severe infections caused by otherwise poorly pathogenic mycobacteria and salmonella. IL-12Rβ1 is a receptor chain of both the IL-12 and the IL-23 receptor and deficiency of IL-12Rβ1 thus abolishes both IL-12 and IL-23 signaling. IL-12Rβ1 deficiency is caused by bi-allelic mutations in the IL12RB1 gene. Mutations resulting in premature stop codons, such as nonsense, frame shift, and splice site mutations, represent the majority of IL-12Rβ1 deficiency causing mutations (66%; 46/70). Also every other morbid mutation completely inactivates the IL-12Rβ1 protein. In addition to disease-causing mutations, rare and common variations with unknown functional effect have been reported in IL12RB1. All these variants have been deposited in the online IL12RB1 variation database (www.LOVD.nl/IL12RB1). In this article, we review the function of IL-12Rβ1 and molecular genetics of human IL12RB1.
Collapse
Affiliation(s)
- Esther van de Vosse
- Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, Al-Muhsen S, Jannière L, Rose Y, Desurenaim M, Kong XF, Filipe-Santos O, Chapgier A, Picard C, Fischer A, Dogu F, Ikinciogullari A, Tanir G, Hajjar SA, Jumaah SA, Frayha HH, AlSum Z, Ajaji SA, Alangari A, Al-Ghonaium A, Adimi P, Mansouri D, Mustapha IB, Yancoski J, Garty BZ, Rodriguez-Gallego C, Caragol I, Kutukculer N, Kumararatne DS, Patel S, Doffinger R, Exley A, Jeppsson O, Reichenbach J, Nadal D, Boyko Y, Pietrucha B, Anderson S, Levin M, Schandené L, Schepers K, Efira A, Mascart F, Matsuoka M, Sakai T, Siegrist CA, Frecerova K, Blüetters-Sawatzki R, Bernhöft J, Freihorst J, Baumann U, Richter D, Haerynck F, De Baets F, Novelli V, Lammas D, Vermylen C, Tuerlinckx D, Nieuwhof C, Pac M, Haas WH, Müller-Fleckenstein I, Fleckenstein B, Levy J, Raj R, Cohen AC, Lewis DB, Holland S, Yang KD, Wang X, Jiang XWL, Yang X, Zhu C, Xie Y, Lee PPW, Chan KW, Chen TX, Castro G, Ivelisse N, Codoceo A, King A, Bezrodnik L, Giovani DD, Gaillard MI, de Moraes-Vasconcelos D, Grumach AS, Duarte AJDS, Aldana R, Espinosa-Rosales FJ, Bejaoui M, Bousfiha AA, El Baghdadi J, Özbek N, Aksu G, Keser M, Somer A, Hatipoglu N, Aydogmus Ç, Asilsoy S, Camcioglu Y, Gülle S, Ozgur TT, Ozen M, Oleastro M, Bernasconi A, Mamishi S, Parvaneh N, Rosenzweig S, Barbouche R, Pedraza S, Lau YL, Ehlayel MS, Fieschi C, Abel L, Sanal O, Casanova JL. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 2010; 89:381-402. [PMID: 21057261 PMCID: PMC3129625 DOI: 10.1097/md.0b013e3181fdd832] [Citation(s) in RCA: 293] [Impact Index Per Article: 20.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Interleukin-12 receptor β1 (IL-12Rβ1) deficiency is the most common form of Mendelian susceptibility to mycobacterial disease (MSMD). We undertook an international survey of 141 patients from 102 kindreds in 30 countries. Among 102 probands, the first infection occurred at a mean age of 2.4 years. In 78 patients, this infection was caused by Bacille Calmette-Guérin (BCG; n = 65), environmental mycobacteria (EM; also known as atypical or nontuberculous mycobacteria) (n = 9) or Mycobacterium tuberculosis (n = 4). Twenty-two of the remaining 24 probands initially presented with nontyphoidal, extraintestinal salmonellosis. Twenty of the 29 genetically affected sibs displayed clinical signs (69%); however 8 remained asymptomatic (27%). Nine nongenotyped sibs with symptoms died. Recurrent BCG infection was diagnosed in 15 cases, recurrent EM in 3 cases, recurrent salmonellosis in 22 patients. Ninety of the 132 symptomatic patients had infections with a single microorganism. Multiple infections were diagnosed in 40 cases, with combined mycobacteriosis and salmonellosis in 36 individuals. BCG disease strongly protected against subsequent EM disease (p = 0.00008). Various other infectious diseases occurred, albeit each rarely, yet candidiasis was reported in 33 of the patients (23%). Ninety-nine patients (70%) survived, with a mean age at last follow-up visit of 12.7 years ± 9.8 years (range, 0.5-46.4 yr). IL-12Rβ1 deficiency is characterized by childhood-onset mycobacteriosis and salmonellosis, rare recurrences of mycobacterial disease, and more frequent recurrence of salmonellosis. The condition has higher clinical penetrance, broader susceptibility to infections, and less favorable outcome than previously thought.
Collapse
|
14
|
Mycobacterium bovis BCG-itis and cervical lymphadenitis due to Salmonella enteritidis in a patient with complete interleukin-12/-23 receptor beta1 deficiency. Infection 2010; 38:128-30. [PMID: 20213287 DOI: 10.1007/s15010-009-9222-0] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2009] [Accepted: 09/28/2009] [Indexed: 10/19/2022]
Abstract
Mendelian susceptibility to mycobacterial disease (MSMD) is a rare disorder with predisposition to severe, sometimes lethal, disease caused by otherwise poorly virulent, non-tuberculous environmental mycobacteria and poorly virulent salmonellae. In patients with MSMD, mutations have been identified in five genes that encode for the proteins IL-12/IL-23p40, IL-12/ IL-23Rbeta1, IFN-R1, IFN-gammaR2 and STAT1. These proteins play important roles in the type-1 cytokine pathway, which is crucial for human host defence against intracellular pathogens such as mycobacteria and salmonellae. We report a girl with mild Mycobacterium bovis Bacille Calmette-Guérin (BCG) disease and Salmonella enteritidis cervical lymphadenitis. Despite treatment, she has remained a fecal carrier of S. enteritidis for the past 14 years. She was found to have complete IL-12/IL-23Rbeta1 deficiency. A homozygous r.518G>C IL12RB1 mutation was identified, leading to a non-functional R173P substitution in the IL-12/IL-23Rbeta1 protein. This mutation abrogated IL-12/IL-23Rbeta1 cell-surface expression and resulted in complete lack of T cell responsiveness to both IL-12 and IL-23.
Collapse
|
15
|
Pedraza-Sánchez S, Herrera-Barrios MT, Aldana-Vergara R, Neumann-Ordoñez M, González-Hernández Y, Sada-Díaz E, de Beaucoudrey L, Casanova JL, Torres-Rojas M. Bacille Calmette-Guérin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families. Int J Infect Dis 2010; 14 Suppl 3:e256-60. [PMID: 20171917 DOI: 10.1016/j.ijid.2009.11.005] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2009] [Revised: 10/31/2009] [Accepted: 11/02/2009] [Indexed: 12/15/2022] Open
Abstract
Patients with Mendelian susceptibility to mycobacterial diseases (MSMD) mainly suffer from Mycobacterium and Salmonella infections, which are due to mutations in genes controlling the interleukin (IL)-12/IL-23-dependent IFN-γ production. We performed a molecular diagnosis in two Mexican patients with persistent mycobacterial infections. Patients 1 (P1) and 2 (P2) from two unrelated, non-consanguineous families from two villages near Mexico City developed bacille Calmette-Guérin (BCG) disease secondary to vaccination; patients and their families were studied at the immunological level for production and response to IFN-γ. The β1 subunit of the IL-12 receptor (encoded by the IL12RB1 gene) was not expressed in cells from P1 or P2, or in two siblings of P1. Sequencing of the IL12RB1 gene showed the same point mutation 1791+2 T>G, homozygous in patients and heterozygous in parents. P1 and P2 died at the ages of 4 and 16 years, respectively, with disseminated and uncontrolled BCG disease and with Candida albicans infections in spite of multiple anti-mycobacterial drug treatments. One of P2's siblings also died following disseminated mycobacterial infection secondary to BCG vaccination. These are the first cases in Mexico of patients with BCG disease traced to a mutation in the IL12RB1 gene, with a fatal outcome. Doctors must be alert to the adverse reactions to BCG vaccination and to persistent Mycobacterium infections, and in such cases should investigate possible mutations in the genes of the IL-12/IL-23-IFN-γ axis.
Collapse
Affiliation(s)
- Sigifredo Pedraza-Sánchez
- Department of Biochemistry, National Institute for Medical Sciences and Nutrition Salvador Zubirán, Vasco de Quiroga 15, Delegación Tlalpan, Mexico.
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Lee PPW, Jiang LP, Wang XC, Chan KW, Tu WW, Lau YL. Severe mycobacterial infections in two pairs of Chinese siblings with interleukin-12 receptor beta1 deficiency. Eur J Pediatr 2008; 167:231-2. [PMID: 17387515 DOI: 10.1007/s00431-007-0430-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2006] [Accepted: 01/18/2007] [Indexed: 11/25/2022]
Affiliation(s)
- P P W Lee
- Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, People's Republic of China
| | | | | | | | | | | |
Collapse
|
17
|
Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, Jouanguy E, Boisson-Dupuis S, Fieschi C, Picard C, Casanova JL. Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006; 18:347-61. [PMID: 16997570 DOI: 10.1016/j.smim.2006.07.010] [Citation(s) in RCA: 327] [Impact Index Per Article: 18.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2006] [Accepted: 07/14/2006] [Indexed: 01/01/2023]
Abstract
Mendelian susceptibility to mycobacterial diseases confers predisposition to clinical disease caused by weakly virulent mycobacterial species in otherwise healthy individuals. Since 1996, disease-causing mutations have been found in five autosomal genes (IFNGR1, IFNGR2, STAT1, IL12B, IL12BR1) and one X-linked gene (NEMO). These genes display a high degree of allelic heterogeneity, defining at least 13 disorders. Although genetically different, these conditions are immunologically related, as all result in impaired IL-12/23-IFN-gamma-mediated immunity. These disorders were initially thought to be rare, but have now been diagnosed in over 220 patients from over 43 countries worldwide. We review here the molecular, cellular, and clinical features of patients with inborn errors of the IL-12/23-IFN-gamma circuit.
Collapse
Affiliation(s)
- Orchidée Filipe-Santos
- Laboratory of Human Genetics of Infectious Diseases, University of Paris René Descartes-INSERM U 550, Necker Medical School, 75015 Paris, France, EU
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Kutukculer N, Genel F, Aksu G, Karapinar B, Ozturk C, Cavusoglu C, Casanova JL, Fieschi C. Cutaneous leukocytoclastic vasculitis in a child with interleukin-12 receptor beta-1 deficiency. J Pediatr 2006; 148:407-9. [PMID: 16615980 DOI: 10.1016/j.jpeds.2005.10.003] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/08/2005] [Revised: 08/11/2005] [Accepted: 10/03/2005] [Indexed: 11/25/2022]
Abstract
We report a patient with complete interleukin-12 receptor beta-1 deficiency associated with cutaneous leukocytoclastic vasculitis. The patient experienced Bacille Calmette Guérin, Mycobacterium chelonae, and Salmonella enteritidis infection. Vasculitis affecting both small arteries and postcapillary venules due to deposition of immune complexes was probably caused by S. enteritidis and/or M. chelonae infection.
Collapse
MESH Headings
- Animals
- Cattle
- Child
- Consanguinity
- Female
- Humans
- Mycobacterium Infections, Nontuberculous/diagnosis
- Mycobacterium Infections, Nontuberculous/drug therapy
- Mycobacterium bovis/isolation & purification
- Mycobacterium chelonae/isolation & purification
- Psoas Abscess/microbiology
- Receptors, Interleukin/deficiency
- Receptors, Interleukin-12
- Salmonella Infections/diagnosis
- Salmonella Infections/drug therapy
- Salmonella enteritidis/isolation & purification
- Splenomegaly/surgery
- Tuberculosis, Bovine/diagnosis
- Tuberculosis, Bovine/drug therapy
- Vasculitis, Leukocytoclastic, Cutaneous/drug therapy
- Vasculitis, Leukocytoclastic, Cutaneous/microbiology
Collapse
Affiliation(s)
- Necil Kutukculer
- Department of Pediatrics, Ege University Medical School, Izmir, Turkey.
| | | | | | | | | | | | | | | |
Collapse
|
19
|
van de Vosse E, de Paus RA, van Dissel JT, Ottenhoff THM. Molecular complementation of IL-12Rβ1 deficiency reveals functional differences between IL-12Rβ1 alleles including partial IL-12Rβ1 deficiency. Hum Mol Genet 2005; 14:3847-55. [PMID: 16293671 DOI: 10.1093/hmg/ddi409] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Patients with mutations in IL12RB1, the gene encoding IL-12Rbeta1, suffer from combined IL-12R/IL-23R deficiency and are unusually susceptible to nontuberculous mycobacteria and salmonellae. The functional effects of amino acid changes in IL-12Rbeta1, however, have not been determined at the molecular level. Molecular complementation studies are essential to demonstrate how structural amino acid changes affect IL-12Rbeta1 function, and whether functionally different IL-12Rbeta1 alleles can be distinguished. Thirteen different IL-12Rbeta1 alleles, including 11 amino acid substitutions and the two major haplotypes (214Q-365M-378G and 214R-365T-378R), were retrovirally transduced in IL-12Rbeta1 deficient human T cells. We provide functional evidence that L77P, R173P, C186S, R213W and Y367C are deleterious mutations leading to non-functional proteins. Conversely, S74R, R156H, H438Y, A525T and G594E are fully functional IL-12Rbeta1 variants. The C198R mutation leads to a partially functional IL-12Rbeta1, representing the first molecularly proven partial IL-12Rbeta1 deficiency. Interleukin-12 (IL-12) induced not only Interferon-gamma but also IL-10 in all responder but not in null-mutant alleles, with intermediate levels in C198R. The QMG allele was found to be a higher IL-12 responder allele compared with the RTR allele. These results have implications for understanding IL-12R/IL-23R structure-function and the role of IL-12R/IL-23R in human disease.
Collapse
Affiliation(s)
- Esther van de Vosse
- Department of Infectious Diseases, Leiden University Medical Center, The Netherlands.
| | | | | | | |
Collapse
|
20
|
Moraes-Vasconcelos DD, Grumach AS, Yamaguti A, Andrade MEB, Fieschi C, de Beaucoudrey L, Casanova JL, Duarte AJS. Paracoccidioides brasiliensis Disseminated Disease in a Patient with Inherited Deficiency in the 1 Subunit of the Interleukin (IL)-12/IL-23 Receptor. Clin Infect Dis 2005; 41:e31-7. [PMID: 16028144 DOI: 10.1086/432119] [Citation(s) in RCA: 95] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2005] [Accepted: 04/14/2005] [Indexed: 11/03/2022] Open
Abstract
BACKGROUND Paracoccidioides brasiliensis is a facultative intracellular dimorphic fungus that causes paracoccidioidomycosis (PCM), the most important deep mycosis in Latin America. Only a small percentage of individuals infected by P. brasiliensis develop clinical PCM, possibly in part because of genetically determined interindividual variability of host immunity. However, no primary immunodeficiency has ever been associated with PCM. METHODS We describe the first patient, to our knowledge, with PCM and a well-defined primary immunodeficiency in the beta 1 subunit of the interleukin (IL)-12/IL-23 receptor, a disorder previously shown to be specifically associated with impaired interferon (IFN)-gamma production, mycobacteriosis, and salmonellosis. RESULTS Our patient had a childhood history of bacille Calmette-Guérin disease and nontyphoid salmonellosis and, at the age of 20 years, presented to our clinic with a disseminated (acute) form of PCM. He responded well to antifungal treatment and is now doing well at 24 years of age. CONCLUSIONS This unique observation supports previous studies of PCM suggesting that IL-12, IL-23, and IFN-gamma play an important role in protective immunity to P. brasiliensis. Tuberculosis and PCM are thus not only related clinically and pathologically, but also by their immunological pathogenesis. Our study further expands the spectrum of clinical manifestations of inherited defects of the IL-12/IL-23-IFN-gamma axis. Patients with unexplained deep fungal infections, such as PCM, should be tested for defects in the IL-12/IL-23-IFN- gamma axis.
Collapse
|
21
|
Abstract
Host genetic factors are important in determining susceptibility and resistance to Mycobacterium tuberculosis. The etiology of tuberculosis is complex, and several host genes have been shown to contribute to the development of clinical disease. The success of the strategies used to investigate host genetic susceptibility to mycobacterial infections can serve as a model for the investigation of host susceptibility to other infectious diseases.
Collapse
Affiliation(s)
- Richard Bellamy
- James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW, UK.
| |
Collapse
|
22
|
Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, Kobrynski LJ, Levinson AI, Mazer B, Nelson RP, Orange JS, Routes JM, Shearer WT, Sorensen RU. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005; 94:S1-63. [PMID: 15945566 DOI: 10.1016/s1081-1206(10)61142-8] [Citation(s) in RCA: 295] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- Francisco A Bonilla
- Department of Medicine, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Ozbek N, Fieschi C, Yilmaz BT, de Beaucoudrey L, Demirhan B, Feinberg J, Bikmaz YE, Casanova JL. Interleukin-12 Receptor 1 Chain Deficiency in a Child with Disseminated Tuberculosis. Clin Infect Dis 2005; 40:e55-8. [PMID: 15736007 DOI: 10.1086/427879] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2004] [Accepted: 11/04/2004] [Indexed: 11/03/2022] Open
Abstract
An 11-year-old girl who presented with disseminated tuberculosis associated with secondary hemophagocytosis received a diagnosis of interleukin-12 receptor beta 1 chain deficiency. This diagnosis of immunodeficiency should, therefore, be considered for children with disseminated tuberculosis, even in the absence of any personal or familial history of prior infection by weakly pathogenic Salmonella and Mycobacterium species.
Collapse
Affiliation(s)
- Namik Ozbek
- Department of Pediatrics, Baskent University School of Medicine, Ankara, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
IL-12, IL-23 and IFN-γ form a loop and have been thought to play a crucial role against infectious viruses, which are the prototype of “intracellular” pathogens. In the last 10 years, the generation of knock-out (KO) mice for genes that control IL-12/IL-23-dependent IFN-γ-dependent mediated immunity (STAT1, IFN-γR1, IFNγR2, IL-12p40 and IL-12Rβ1) and the identification of patients with spontaneous germline mutations in these genes has led to a re-examination of the role of these cytokines in anti-viral immunity. We here review viral infections in mice and humans with genetic defects in the IL-12/IL-23-IFN-γ axis. A comparison of the phenotypes observed in KO mice and deficient patients suggests that the human IL-12/IL-23-IFN-γ axis plays a redundant role in immunity to most viruses, whereas its mouse counterparts play a more important role against several viruses.
Collapse
Affiliation(s)
- Francesco Novelli
- Laboratory of Human Genetics of Infectious Diseases, Necker Medical School, René Descartes University of Paris, INSERM U550, 156 Rue de Vaugirard, 75015 Paris, France.
| | | |
Collapse
|
25
|
Ulrichs T, Fieschi C, Nevicka E, Hahn H, Brezina M, Kaufmann SHE, Casanova JL, Frecerova K. Variable outcome of experimental interferon-gamma therapy of disseminated Bacillus Calmette-Guerin infection in two unrelated interleukin-12Rbeta1-deficient Slovakian children. Eur J Pediatr 2005; 164:166-72. [PMID: 15633050 DOI: 10.1007/s00431-004-1599-2] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/29/2004] [Accepted: 11/03/2004] [Indexed: 11/30/2022]
Abstract
UNLABELLED Mycobacterium bovis Bacillus Calmette-Guerin (BCG) is an attenuated live vaccine that may cause life-threatening clinical disease in children with impaired immunity. In particular, patients with any of the nine known inherited disorders of the interleukin-12/23 interferon-gamma (IL-12/23-IFNgamma) axis are highly vulnerable to BCG. We describe two unrelated young Slovakian children suffering from disseminated BCG infection which developed shortly after routine BCG vaccination after birth. During treatment with selected anti-BCG antibiotics, resistance against several of these drugs developed. In both children, interleukin-12/23 receptor beta1 (IL-12/23Rbeta1) deficiency was diagnosed. Thus, in addition to chemotherapy, immunomodulatory treatment with recombinant IFN-gamma was performed as the pathogenesis of BCG disease in IL-12Rbeta1 deficiency involves impaired IL-12- and IL-23-dependent IFN-gamma production by lymphocytes. One child responded to treatment and is presently doing well whereas the second patient died. CONCLUSION The marked variability of outcome of disseminated Bacillus Calmette-Guerin disease in interleukin-12/23 receptor beta1-deficient children sharing the same ethnic origin and exposed to a similar environment as presented in these case reports has to be taken into consideration for diagnosis and treatment of infections due to this genetic defect.
Collapse
Affiliation(s)
- Timo Ulrichs
- Department of Immunology, Max-Planck-Institute for Infection Biology, Berlin, Germany
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Bosticardo M, Witte I, Fieschi C, Novelli F, Casanova JL, Candotti F. Retroviral-mediated gene transfer restores IL-12 and IL-23 signaling pathways in T cells from IL-12 receptor beta1-deficient patients. Mol Ther 2005; 9:895-901. [PMID: 15194056 DOI: 10.1016/j.ymthe.2004.02.024] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2003] [Accepted: 02/20/2004] [Indexed: 01/16/2023] Open
Abstract
Genetic deficiency of human IL-12 receptor beta1 chain (IL-12Rbeta1) results in increased vulnerability to weakly pathogenic strains of Mycobacteria and Salmonella. This phenotype results from the combined lack of IL-12 and IL-23 signaling as both cytokine receptors share IL-12Rbeta1. Such infections can be treated by administration of antibiotics and IFN-gamma; however, patients can succumb to infections despite these treatments. Reversion of patients' susceptibility by corrective gene transfer could prevent the infectious episodes, thus providing a beneficial alternative. We therefore evaluated the feasibility of retroviral-mediated gene correction of T cells obtained from patients carrying "null" mutations of IL-12Rbeta1. Transduction of the IL-12Rbeta1 cDNA restored the expression of IL-12Rbeta1 and resulted in the reconstitution of a functional IL-12 signaling pathway, as demonstrated by STAT4 phosphorylation and IFN-gamma production. IFN-gamma production in response to IL-23 was also corrected after gene transfer. These results indicate that the biological defects of T cells from patients carrying IL-12Rbeta1 deficiency can be corrected by gene transfer and form the basis for further development of gene therapy for this disease.
Collapse
Affiliation(s)
- Marita Bosticardo
- Disorders of Immunity Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, 49 Convent Drive, Building 49, Room 3A20, MSC 4442, Bethesda, MD 20892-4442, USA
| | | | | | | | | | | |
Collapse
|
27
|
Ottenhoff THM, Verreck FAW, Hoeve MA, van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis (Edinb) 2004; 85:53-64. [PMID: 15687028 DOI: 10.1016/j.tube.2004.09.011] [Citation(s) in RCA: 135] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2004] [Accepted: 09/27/2004] [Indexed: 11/25/2022]
Abstract
Infection with Mycobacterium tuberculosis results in disease in 5-10% of exposed individuals, whereas the remainder controls infection effectively. Similar inter-individual differences in disease susceptibility are characteristic features of leprosy, typhoid fever, leishmaniasis and other chronic infectious diseases, including viral infections. Although the outcome of infection is influenced by many factors, it is clear that genetic host factors play an important role in controlling disease susceptibility to intracellular pathogens. Knowledge of the genes involved and their downstream cellular pathways will provide new insights for the design of improved and rationalized strategies to enhance host-resistance, e.g. by vaccination. In addition, this knowledge will aid in identifying better biomarkers of protection and disease, which are essential tools for the monitoring of vaccination and other intervention trials. The recent identification of patients with deleterious mutations in genes that encode major proteins in the type-1 cytokine (IL-12/IL23-IFN-gamma) axis, that suffered from severe infections due to otherwise poorly pathogenic mycobacteria (non-tuberculous mycobacteria (NTM) or M. bovis Bacille Calmette-Guerin (BCG)) or Salmonella species has revealed the major role of this system in innate and adaptive immunity to mycobacteria and salmonellae. Clinical tuberculosis has now been described in a number of patients with IL-12/IL23-IFN-gamma system defects. Moreover, unusual mycobacterial infections were reported in several patients with genetic defects in NEMO, a key regulatory molecule in the NFkappaB pathway. These new findings will be discussed since they provide further insights into the role of type-1 cytokines in immunity to mycobacteria, including M. tuberculosis.
Collapse
Affiliation(s)
- Tom H M Ottenhoff
- Department Immunohematology and Blood Transfusion, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands.
| | | | | | | |
Collapse
|
28
|
Abstract
PURPOSE OF REVIEW Cytokines are soluble mediators involved in the development or function of the immune system. This paper reviews the literature on childhood-onset inherited disorders associated with impaired cytokine-mediated immunity. RECENT FINDINGS Cytokine-mediated immunity defects can be classified into seven different groups: defects in the interleukin (IL)-7 receptor (IL7RA), in the common cytokine receptor gamma chain (gammac) of the IL-2, -4, -7, -15, and -21, and in Jak3 (JAK3) downstream of the gamma chain; mutation in the IL-2 receptor alpha (IL-2RA) and defective expression of the IL-2Rbeta chain; mutations in the gene encoding for a chemokine receptor, CXCR4; mutations in five genes involved in the IL-12/23-interferon-gamma axis (IL12B, IL12RB1, IFNGR1, IFNGR2, STAT1); mutations in three genes involved in the nuclear factor-kappaB signaling pathway (IRAK4, NEMO, IkappaBA); mutations in the tumor necrosis factor receptor signaling pathway (TNFRSF1A); and mutations in the transforming growth factor-1 gene (TGFB1). SUMMARY Genetic cytokine-mediated immunity defects are associated with a highly heterogeneous group of clinical features, ranging from susceptibility to infections to developmental defects. This heterogeneity highlights the diversity and pleiotropy of cytokines. It is likely that many more cytokine defects and their responsive pathways will be discovered in the coming years, expanding further the heterogeneity associated with this group of childhood-onset illnesses.
Collapse
Affiliation(s)
- Capucine Picard
- Unité d'Immunologie et d'Hématologie Pédiatriques, Hôpital Necker-Enfants Malades, and Laboratoire de Génétique Humaine des Maladies Infectieuses, Université de Paris René Descartes-INSERM U550, Faculté de Médecine Necker, Paris, France.
| | | |
Collapse
|
29
|
van de Vosse E, Hoeve MA, Ottenhoff THM. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. THE LANCET. INFECTIOUS DISEASES 2004; 4:739-49. [PMID: 15567123 DOI: 10.1016/s1473-3099(04)01203-4] [Citation(s) in RCA: 156] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
The ability to develop adequate immunity to intracellular bacterial pathogens is unequally distributed among human beings. In the case of tuberculosis, for example, infection with Mycobacterium tuberculosis results in disease in 5-10% of exposed individuals, whereas the remainder control infection effectively. Similar interindividual differences in disease susceptibility are characteristic features of leprosy, typhoid fever, leishmaniasis, and other chronic infectious diseases, including viral infections. The outcome of infection is influenced by many factors, such as nutritional status, co-infections, exposure to environmental microbes, and previous vaccinations. It is clear, however, that genetic host factors also play an important part in controlling disease susceptibility to intracellular pathogens. Recently, patients with severe infections due to otherwise poorly pathogenic mycobacteria (non-tuberculous mycobacteria or Mycobacterium bovis BCG) or Salmonella spp have been identified. Many of these patients were unable to produce or respond to interferon gamma, due to deleterious mutations in genes that encode major proteins in the type 1 cytokine (interleukin 12/interleukin 23/interferon gamma) axis (interleukin 12p40/interleukin 23p40, IL12 receptor beta1/IL23 receptor beta1, interferon gamma receptors 1 and 2, or signal transducer and activator of transcription 1). This axis is a major immunoregulatory system that bridges innate and adaptive immunity. Unusual mycobacterial infections were also reported in several patients with genetic defects in inhibitor of NFkappaB kinase gamma, a key regulatory molecule in the nuclear factor kappaB pathway. New findings discussed in this review provide further and sometimes surprising insights into the role of type 1 cytokines, and into the unexpected heterogeneity seen in these syndromes.
Collapse
Affiliation(s)
- Esther van de Vosse
- Department of Infectious Diseases, Leiden University Medical Centre, Leiden, Netherlands
| | | | | |
Collapse
|
30
|
Russell TD, Yan Q, Fan G, Khalifah AP, Bishop DK, Brody SL, Walter MJ. IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1. THE JOURNAL OF IMMUNOLOGY 2004; 171:6866-74. [PMID: 14662893 DOI: 10.4049/jimmunol.171.12.6866] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Leukocyte recruitment to the airway lumen is a central feature of inflammatory conditions such as asthma and respiratory viral infection. Characterization of mediators that regulate leukocyte recruitment in these conditions revealed increased IL-12 p40 homodimer (p80) levels were associated with enhanced airway macrophage accumulation. To examine this association, we used in vivo and in vitro assays to demonstrate p80, but not IL-12 or p40, provided a macrophage chemoattractant signal. Macrophages from genetically deficient mice indicated p80-dependent chemotaxis was independent of IL-12 and required IL-12Rbeta1 (Rbeta1) expression. Furthermore, analysis of murine cell lines and primary culture macrophages revealed Rbeta1 expression, with an intact cytoplasmic tail, was necessary and sufficient to mediate p80-dependent chemotaxis. To examine the role for Rbeta1 in mediating macrophage accumulation in vivo, we contrasted Sendai virus-driven airway inflammation in wild-type and Rbeta1-deficient mice. Despite similar viral burden and production of the macrophage chemoattractant p80, the Rbeta1-deficient mice displayed a selective decrease in airway macrophage accumulation and resistance to viral-dependent mortality. Thus, Rbeta1 mediates p80-dependent macrophage chemotaxis and inhibition of the p80-Rbeta1 interaction may provide a novel anti-inflammatory strategy to manipulate the inflammation associated with asthma and respiratory viral infection.
Collapse
MESH Headings
- Animals
- Antigens, CD/chemistry
- Antigens, CD/physiology
- Chemotactic Factors/chemistry
- Chemotactic Factors/physiology
- Chemotaxis/immunology
- Cytoplasm/chemistry
- Cytoplasm/genetics
- Dimerization
- Down-Regulation/genetics
- Down-Regulation/immunology
- Interleukin-12/chemistry
- Interleukin-12/physiology
- Interleukin-12 Subunit p40
- Macrophages, Alveolar/immunology
- Macrophages, Alveolar/pathology
- Macrophages, Alveolar/virology
- Macrophages, Peritoneal/cytology
- Macrophages, Peritoneal/immunology
- Macrophages, Peritoneal/metabolism
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Knockout
- NIH 3T3 Cells
- Protein Subunits/chemistry
- Protein Subunits/physiology
- Receptors, Interleukin/biosynthesis
- Receptors, Interleukin/deficiency
- Receptors, Interleukin/genetics
- Receptors, Interleukin/physiology
- Receptors, Interleukin-12
- Receptors, Tumor Necrosis Factor/chemistry
- Receptors, Tumor Necrosis Factor/physiology
- Receptors, Tumor Necrosis Factor, Type II
- Respiratory Tract Infections/genetics
- Respiratory Tract Infections/immunology
- Respiratory Tract Infections/pathology
- Respirovirus Infections/genetics
- Respirovirus Infections/immunology
- Respirovirus Infections/pathology
- Sendai virus/immunology
- Sequence Deletion
Collapse
Affiliation(s)
- Tonya D Russell
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
| | | | | | | | | | | | | |
Collapse
|
31
|
Andrews T, Sullivan KE. Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev 2003; 16:597-621. [PMID: 14557288 PMCID: PMC207096 DOI: 10.1128/cmr.16.4.597-621.2003] [Citation(s) in RCA: 117] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Patients with defects in phagocytic function are predisposed to intracellular microorganisms and typically have early dissemination of the infection. Recognition of the underlying disorder and aggressive antimicrobial therapy has been beneficial for the patients. Improved understanding of the pathophysiology has also affected patient management by allowing specific, targeted immunomodulatory intervention. The disorders described in this review are not common but have had a significant impact on our understanding of the role of phagocytic cells in host defense. Conversely, understanding the role of the neutrophil and macrophage in infection has benefited not just the patients described in this review but also other patients with similar disease processes.
Collapse
Affiliation(s)
- Timothy Andrews
- Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
| | | |
Collapse
|
32
|
Caragol I, Raspall M, Fieschi C, Feinberg J, Larrosa MN, Hernández M, Figueras C, Bertrán JM, Casanova JL, Español T. Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency. Clin Infect Dis 2003; 37:302-6. [PMID: 12856223 DOI: 10.1086/375587] [Citation(s) in RCA: 94] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2002] [Accepted: 02/19/2003] [Indexed: 11/03/2022] Open
Abstract
We describe 3 siblings with interleukin-12 receptor beta1 (IL-12Rbeta1) deficiency, a known genetic etiology of clinical disease caused by infection with poorly virulent mycobacteria, such as mycobacteria found in bacille Calmette-Guérin (BCG) vaccines and environmental nontuberculous mycobacteria (NTM). One child had disseminated tuberculosis, the second had extraintestinal salmonellosis and pulmonary tuberculosis, and the third remained asymptomatic. IL-12Rbeta1 deficiency should be considered as a diagnosis in patients with severe salmonellosis or tuberculosis, even if they do not have disease due to BCG or NTM.
Collapse
Affiliation(s)
- Isabel Caragol
- Immunology Unit, Hospital Vall d'Hebron, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Staretz-Haham O, Melamed R, Lifshitz M, Porat N, Fieschi C, Casanova JL, Levy J. Interleukin-12 receptor beta1 deficiency presenting as recurrent Salmonella infection. Clin Infect Dis 2003; 37:137-40. [PMID: 12830418 DOI: 10.1086/375229] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2002] [Accepted: 02/14/2002] [Indexed: 11/03/2022] Open
Abstract
We describe a child with interleukin-12 receptor beta1 (IL-12Rbeta1) deficiency caused by a homozygous IL12RB1 large deletion who presented at the age of 1 year with recurrent, often asymptomatic episodes of bacteremia caused by group D Salmonella species. No mycobacterial disease or other unusual infection was present. The episodes of salmonellosis were caused by an identical serovar during a period of 18 months. This is the first case of inherited IL-12Rbeta1 deficiency diagnosed after isolated, recurrent salmonellosis.
Collapse
Affiliation(s)
- Orna Staretz-Haham
- Pediatric Department, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel 84101
| | | | | | | | | | | | | |
Collapse
|
34
|
Jo EK, Park JK, Dockrell HM. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis 2003; 16:205-10. [PMID: 12821809 DOI: 10.1097/00001432-200306000-00004] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE OF REVIEW Cytokines have been implicated in the protective immunity, pathophysiology and development of tuberculosis. Most people who become infected with Mycobacterium tuberculosis mount an effective protective immune response, but 5-10% develop disease. Active pulmonary tuberculosis can be considered to reflect an ineffective immune response against mycobacterial infection. A better understanding of how cytokine production contributes to immunity and pathology would aid the development of new vaccines and therapeutic strategies. RECENT FINDINGS At the time of diagnosis, production of M. tuberculosis or mycobacterial antigen-induced interferon-gamma by peripheral blood mononuclear cells from tuberculosis patients is usually depressed, compared with that of healthy control subjects, whereas cytokine production at the site of disease is elevated. In most patients, depressed interferon-gamma production by peripheral blood mononuclear cells seems to be a transient response because it is significantly increased in most active tuberculosis patients during and following successful antituberculous therapy. However, some patients remain anergic in vivo and in vitro after chemotherapy, and the underlying biochemical mechanisms for T cell anergy in modulating protection or pathology in tuberculosis needs further clarification. Among the cytokines contributing to protective immunity, interleukins 12 and 18, and tumour necrosis factor-alpha are important, the basis of recent studies with tuberculosis patients. SUMMARY A more complete understanding of cytokine dynamics in individual cells in active pulmonary tuberculosis patients will provide further knowledge about immunopathogenesis and protective immunity in human tuberculosis. This should ultimately enhance development of preventive and therapeutic strategies against this enormously successful intracellular pathogen.
Collapse
Affiliation(s)
- Eun-Kyeong Jo
- Department of Microbiology, College of Medicine, Chungnam National University, Daejeon, Korea.
| | | | | |
Collapse
|
35
|
van de Vosse E, Lichtenauer-Kaligis EGR, van Dissel JT, Ottenhoff THM. Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics 2003; 54:817-29. [PMID: 12671732 DOI: 10.1007/s00251-002-0534-9] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2002] [Accepted: 12/09/2002] [Indexed: 02/08/2023]
Abstract
Cell-mediated immunity (CMI) plays an essential role in human host defense against intracellular bacteria. Type-1 cytokines, particularly gamma interferon (IFN-gamma), interleukin-12 (IL-12), and IL-23, the major cytokines that regulate IFN-gamma production, are essential in CMI. This is illustrated by patients with unusual severe infections caused by poorly pathogenic mycobacteria and Salmonella species, in whom genetic deficiencies have been identified in several key genes in the type-1 cytokine pathway, including IL12RB1, the gene encoding the beta1 chain of the IL-12 and IL-23 receptors. Several mutations in IL12RB1 with deleterious effects on human IL-12R function have been identified, including nonsense and missense mutations. In addition, a number of coding IL12RB1 polymorphisms have been reported. In order to gain more insight into the effect that IL12RB1 mutations and genetic variations can have on IL-12Rbeta1 function, three approaches have been followed. First, we determined the degree of conservation at the variant amino acid positions in IL-12Rbeta1 between different species, using known deleterious mutations, known variations in IL-12Rbeta1, as well as novel coding variations that we have identified at position S74R and R156H. Second, we analyzed the potential impact of these amino acid variations on the three-dimensional structure of the IL-12Rbeta1 protein. Third, we analyzed the putative functions of different IL-12Rbeta1 domains, partly based on their homology with gp130, and analyzed the possible effects of the above amino acid variations on the function of these domains. Based on these analyses, we propose an integrated model of IL-12Rbeta1 structure and function. This significantly enhances our molecular understanding of the human IL-12 and IL-23 systems.
Collapse
Affiliation(s)
- Esther van de Vosse
- Department of Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, The Netherlands
| | | | | | | |
Collapse
|
36
|
Akahoshi M, Nakashima H, Miyake K, Inoue Y, Shimizu S, Tanaka Y, Okada K, Otsuka T, Harada M. Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. Hum Genet 2003; 112:237-43. [PMID: 12596048 DOI: 10.1007/s00439-002-0873-5] [Citation(s) in RCA: 74] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2002] [Accepted: 11/01/2002] [Indexed: 01/23/2023]
Abstract
Host genetic factors may be important determinants of susceptibility to tuberculosis, and several candidate gene polymorphisms have been shown to date. A series of recent reports concerning rare human deficiencies in the type-1 cytokine pathway suggest that more subtle variants of relevant genes may also contribute to susceptibility to tuberculosis at the general population level. To investigate whether polymorphisms in the interleukin-12 receptor (IL-12R) gene predispose individuals to tuberculosis, we studied these genes by single-strand conformational polymorphism analysis and direct sequencing. Although no common polymorphisms could be identified in the IL-12R beta 2 gene ( IL-12RB2), we confirmed four single nucleotide polymorphisms (SNPs; 641A-->G, 684C-->T, 1094T-->C, and 1132G-->C) causing three missense variants (Q214R, M365T, G378R) and one synonymous substitution in the extracellular domain of the IL-12R beta 1 gene ( IL12RB1). All SNPs were in almost perfect linkage disequilibrium (D'=0.98), and two common haplotypes of IL12RB1(allele 1: Q214-M365-G378; allele 2: R214-T365-R378) were revealed. Polymerase chain reaction/restriction fragment length polymorphism and sequence analyses were used to type IL12RB1polymorphisms in 98 patients with tuberculosis and 197 healthy controls in Japanese populations. In our case-control association study of tuberculosis, the R214-T365-R378 allele (allele 2) was over-represented in patients with tuberculosis, and homozygosity for R214-T365-R378 (the 2/2 genotype) was significantly associated with tuberculosis (odds ratio: 2.45; 95% CI: 1.20-4.99; P=0.013). In healthy subjects, homozygotes for R214-T365-R378 had lower levels of IL-12-induced signaling, according to differences in cellular responses to IL-12 between two haplotypes. These data suggest that the R214-T365-R378 allele, i.e., variation in IL12RB1, contribute to tuberculosis susceptibility in the Japanese population. This genetic variation may predispose individuals to tuberculosis infection by diminishing receptor responsiveness to IL-12 and to IL-23, leading to partial dysfunction of interferon-gamma-mediated immunity.
Collapse
Affiliation(s)
- Mitsuteru Akahoshi
- Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, Koch H, Richter D, Brezina M, Aksu G, Wood P, Al-Jumaah S, Raspall M, Da Silva Duarte AJ, Tuerlinckx D, Virelizier JL, Fischer A, Enright A, Bernhöft J, Cleary AM, Vermylen C, Rodriguez-Gallego C, Davies G, Blütters-Sawatzki R, Siegrist CA, Ehlayel MS, Novelli V, Haas WH, Levy J, Freihorst J, Al-Hajjar S, Nadal D, De Moraes Vasconcelos D, Jeppsson O, Kutukculer N, Frecerova K, Caragol I, Lammas D, Kumararatne DS, Abel L, Casanova JL. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 2003; 197:527-35. [PMID: 12591909 PMCID: PMC2193866 DOI: 10.1084/jem.20021769] [Citation(s) in RCA: 219] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
Abstract
The clinical phenotype of interleukin 12 receptor beta1 chain (IL-12Rbeta1) deficiency and the function of human IL-12 in host defense remain largely unknown, due to the small number of patients reported. We now report 41 patients with complete IL-12Rbeta1 deficiency from 17 countries. The only opportunistic infections observed, in 34 patients, were of childhood onset and caused by weakly virulent Salmonella or Mycobacteria (Bacille Calmette-Guérin -BCG- and environmental Mycobacteria). Three patients had clinical tuberculosis, one of whom also had salmonellosis. Unlike salmonellosis, mycobacterial infections did not recur. BCG inoculation and BCG disease were both effective against subsequent environmental mycobacteriosis, but not against salmonellosis. Excluding the probands, seven of the 12 affected siblings have remained free of case-definition opportunistic infection. Finally, only five deaths occurred in childhood, and the remaining 36 patients are alive and well. Thus, a diagnosis of IL-12Rbeta1 deficiency should be considered in children with opportunistic mycobacteriosis or salmonellosis; healthy siblings of probands and selected cases of tuberculosis should also be investigated. The overall prognosis is good due to broad resistance to infection and the low penetrance and favorable outcome of infections. Unexpectedly, human IL-12 is redundant in protective immunity against most microorganisms other than Mycobacteria and Salmonella. Moreover, IL-12 is redundant for primary immunity to Mycobacteria and Salmonella in many individuals and for secondary immunity to Mycobacteria but not to Salmonella in most.
Collapse
Affiliation(s)
- Claire Fieschi
- Laboratory of Human Genetics of Infectious Diseases, University René Descartes INSERM U550, Necker Medical School, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Lichtenauer-Kaligis EGR, de Boer T, Verreck FAW, van Voorden S, Hoeve MA, van de Vosse E, Ersoy F, Tezcan I, van Dissel JT, Sanal O, Ottenhoff THM. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency. Eur J Immunol 2003; 33:59-69. [PMID: 12594833 DOI: 10.1002/immu.200390008] [Citation(s) in RCA: 66] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Cell mediated immunity plays a critical role in human host defence against intracellular bacteria. In patients with unusual, severe infections caused by poorly pathogenic species of mycobacteria and salmonellae, genetic deficiencies have been identified in key genes in the type-1 cytokine pathway, especially in IFNGR1 and IL12RB1. Here, we analyzed 11 patients originating from Turkey and suffering from unusual Mycobacterium bovis Bacille Calmette-Guerin infections following vaccination, and found that most patients (n=8) are deficient in IL-12Rbeta1 expression and function. No defects were found in patients' IFN-gammaR or IL-18R. In addition, a first patient suffering from partial IL-12Rbeta1 deficiency is described. This patient presented with an intermediate cellular and immunological phenotype: a consistent, low response to IL-12 was found, which could be further augmented by IL-18. Despite a lack of cell surface IL-12Rbeta1 expression, normal levels of intracellular IL-12Rbeta1 protein were detectable, which was not seen in the other, completely IL-12Rbeta1 deficient patients examined. Moreover, this patient had a relatively mild clinical phenotype and was the only individual with a single homozygous amino acid substitution in IL-12Rbeta1 (C198R). Collectively, our findings indicate that idiopathic, unusually severe infections due to M. bovis BCG can be caused by complete as well as partial IL-12Rbeta1 deficiency.
Collapse
MESH Headings
- Child
- DNA Mutational Analysis
- Female
- Flow Cytometry
- Genetic Predisposition to Disease
- Heterozygote
- Humans
- Interleukin-12/immunology
- Interleukin-18 Receptor alpha Subunit
- Male
- Mycobacterium Infections, Nontuberculous/genetics
- Mycobacterium Infections, Nontuberculous/immunology
- Pedigree
- RNA, Messenger/genetics
- RNA, Messenger/metabolism
- Receptors, Interferon/genetics
- Receptors, Interleukin/analysis
- Receptors, Interleukin/deficiency
- Receptors, Interleukin/genetics
- Receptors, Interleukin/immunology
- Receptors, Interleukin-12
- Receptors, Interleukin-18
- Turkey
- Interferon gamma Receptor
Collapse
|
39
|
Abstract
There is substantial evidence that host genetic factors are important in determining susceptibility to mycobacteria. Several different techniques have been used to identify the genes involved. Studies of an inbred strain of mice with increased susceptibility to mycobacteria, salmonella and leishmania infections led to the identification of the natural resistance-associated macrophage protein gene (Nramp1). Case-control studies have confirmed the importance of the human equivalent of this gene, NRAMP1, and have also suggested that the major histocompatibility complex and vitamin-D receptor genes may be involved in determining human susceptibility to mycobacteria. Studies of individuals with the rare condition of increased susceptibility to disseminated bacille Calmette-Guerin and other atypical mycobacterial infections have identified several abnormalities in the genes encoding the interferon gamma receptor (IFNgammaR) ligand binding chain, IFNgammaR signal transduction chain, IFNgamma signal transduction and activation of transcription-1, interleukin 12 receptor beta1 subunit and interleukin 12 p40 subunit. A genome-wide linkage study has been performed to identify genes exerting a major effect on tuberculosis susceptibility in the general population. Linkages were found to markers on chromosomes 15 and X. Studies to identify the genes responsible are in progress.
Collapse
Affiliation(s)
- R Bellamy
- Department of Experimental Medicine, Singleton Hospital, Swansea, South Wales, UK.
| |
Collapse
|
40
|
Ottenhoff THM, Verreck FAW, Lichtenauer-Kaligis EGR, Hoeve MA, Sanal O, van Dissel JT. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 2002; 32:97-105. [PMID: 12205477 DOI: 10.1038/ng0902-97] [Citation(s) in RCA: 183] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Host genetic factors are important in determining the outcome of infections caused by intracellular pathogens, including mycobacteria and salmonellae, but until now have been poorly characterized. Recently, some individuals with severe infections due to otherwise weakly pathogenic mycobacteria (non-tuberculous mycobacteria or Mycobacterium bovis bacille Calmette-Guérin) or Salmonella species have been shown to be unable to produce or respond to interferon-gamma. This inability results from mutations in any of five genes encoding essential proteins of the type 1 cytokine cascade: interleukin-12p40, interleukin-12R beta 1, interferon-gamma R1, interferon-gamma R2 or STAT1. Ten syndromes have thus far been identified. Recent insights in genetically controlled host defense and susceptibility to mycobacterial disease are discussed.
Collapse
Affiliation(s)
- Tom H M Ottenhoff
- Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.
| | | | | | | | | | | |
Collapse
|
41
|
Quinn JV, Steele RW. Ventriculitis following a neurosurgic procedure. Clin Pediatr (Phila) 2002; 41:439-41. [PMID: 12166797 DOI: 10.1177/000992280204100610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- John V Quinn
- Department of Pediatrics, LSU Health Science Center and Children's Hospital, New Orleans, Louisiana 70118, USA
| | | |
Collapse
|
42
|
Abstract
Humans are exposed to a variety of environmental mycobacteria (EM), and most children are inoculated with live Bacille Calmette-Guérin (BCG) vaccine. In addition, most of the world's population is occasionally exposed to human-borne mycobacterial species, which are less abundant but more virulent. Although rarely pathogenic, mildly virulent mycobacteria, including BCG and most EM, may cause a variety of clinical diseases. Mycobacterium tuberculosis, M. leprae, and EM M. ulcerans are more virulent, causing tuberculosis, leprosy, and Buruli ulcer, respectively. Remarkably, only a minority of individuals develop clinical disease, even if infected with virulent mycobacteria. The interindividual variability of clinical outcome is thought to result in part from variability in the human genes that control host defense. In this well-defined microbiological and clinical context, the principles of mouse immunology and the methods of human genetics can be combined to facilitate the genetic dissection of immunity to mycobacteria. The natural infections are unique to the human model, not being found in any of the animal models of experimental infection. We review current genetic knowledge concerning the simple and complex inheritance of predisposition to mycobacterial diseases in humans. Rare patients with Mendelian disorders have been found to be vulnerable to BCG, a few EM, and M. tuberculosis. Most cases of presumed Mendelian susceptibility to these and other mycobacterial species remain unexplained. In the general population leprosy and tuberculosis have been shown to be associated with certain human genetic polymorphisms and linked to certain chromosomal regions. The causal vulnerability genes themselves have yet to be identified and their pathogenic alleles immunologically validated. The studies carried out to date have been fruitful, initiating the genetic dissection of protective immunity against a variety of mycobacterial species in natural conditions of infection. The human model has potential uses beyond the study of mycobacterial infections and may well become a model of choice for the investigation of immunity to infectious agents.
Collapse
Affiliation(s)
- Jean-Laurent Casanova
- Laboratory of Human Genetics of Infectious Diseases, Université René Descartes-INSERM U550, Necker Medical School, 156 rue de Vaugirard, 75015 Paris, France.
| | | |
Collapse
|
43
|
Döffinger R, Dupuis S, Picard C, Fieschi C, Feinberg J, Barcenas-Morales G, Casanova JL. Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update. Mol Immunol 2002; 38:903-9. [PMID: 12009568 DOI: 10.1016/s0161-5890(02)00017-2] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
In the last 6 years, considerable advances have been made in the molecular analysis of a rare clinical syndrome: Mendelian susceptibility to mycobacterial disease (MSMD). Infection with poorly virulent environmental non-tuberculous mycobacteria (NTM) or vaccination with bacillus Calmette-Guerin (BCG) may cause disseminating and even fatal disease in individuals suffering from this syndrome. Mutations in five genes (IFNGR1, IFNGR2, STAT1, IL12B and IL12RB1) have been shown to be responsible for MSMD and further allelic heterogeneity accounts for the existence of nine distinct inherited disorders. All of these disorders are caused by impaired IFNgamma-mediated immunity. These results have important medical and biological implications. In this report, we update the disease-causing mutations reported in the literature.
Collapse
Affiliation(s)
- R Döffinger
- Laboratory of Human Genetics of Infectious Diseases, Necker Medical School, 156 rue de Vaugirard, 75015 Paris, France
| | | | | | | | | | | | | |
Collapse
|
44
|
Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, Dupuis S, Soudais C, Al-Mohsen IZ, Génin E, Lammas D, Kumararatne DS, Leclerc T, Rafii A, Frayha H, Murugasu B, Wah LB, Sinniah R, Loubser M, Okamoto E, Al-Ghonaium A, Tufenkeji H, Abel L, Casanova JL. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002; 70:336-48. [PMID: 11753820 PMCID: PMC384913 DOI: 10.1086/338625] [Citation(s) in RCA: 211] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2001] [Accepted: 11/05/2001] [Indexed: 11/03/2022] Open
Abstract
Interleukin-12 (IL12) is a cytokine that is secreted by activated phagocytes and dendritic cells and that induces interferon-gamma production by natural-killer and T lymphocytes. It consists of two subunits, p35 and p40, which are encoded by IL12A and IL12B, respectively. The first reported patient with a genetic cytokine disorder was a Pakistani child, who was homozygous for a large loss-of-function deletion (g.482+82_856-854del) in IL12B. This IL12-deficient child suffered from infections caused by bacille Calmette-Guérin (BCG) and Salmonella enteritidis. We herein report 12 additional patients from five other kindreds. In one kindred from India, the same large deletion that was described elsewhere (g.482+82_856-854del) was identified. In four kindreds from Saudi Arabia, a recessive loss-of-function frameshift insertion (g.315_316insA) was found. A conserved haplotype encompassing the IL12B gene suggested that a founder effect accounted for the recurrence of each mutation. The two founder mutational events-g.482+82_856-854del and g.315_316insA-were estimated to have occurred approximately 700 and approximately 1,100 years ago, respectively. Among a total of 13 patients with IL12 deficiency, 1 child had salmonellosis only and 12 suffered from clinical disease due to BCG or environmental nontuberculous mycobacteria. One patient also had clinical disease caused by virulent Mycobacterium tuberculosis, five patients had clinical disease caused by Salmonella serotypes, and one patient had clinical disease caused by Nocardia asteroides. The clinical outcome varies from case to case, since five patients (aged 2-11 years) died of overwhelming infection, whereas eight patients (aged 3-12 years) are still in good health and are not currently taking antibiotics. In conclusion, IL12 deficiency is not limited to a single kindred, shows significant variability of outcome, and should be considered in the genetic diagnosis of patients with mycobacteriosis and/or salmonellosis. To date, two founder IL12B mutations have been identified, accounting for the recurrence of a large deletion and a small insertion within populations from the Indian subcontinent and from the Arabian Peninsula, respectively.
Collapse
Affiliation(s)
- Capucine Picard
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Claire Fieschi
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Frédéric Altare
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Suliman Al-Jumaah
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Sami Al-Hajjar
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Jacqueline Feinberg
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Stéphanie Dupuis
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Claire Soudais
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Ibrahim Zaid Al-Mohsen
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Emmanuelle Génin
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - David Lammas
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Dinakantha S. Kumararatne
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Tony Leclerc
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Arash Rafii
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Husn Frayha
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Belinda Murugasu
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Lee Bee Wah
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Raja Sinniah
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Michael Loubser
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Emi Okamoto
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Abdulaziz Al-Ghonaium
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Haysam Tufenkeji
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Laurent Abel
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| | - Jean-Laurent Casanova
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes INSERM U550, Faculté de Médecine Necker, and Unité d’Immunologie et d’Hématologie Pédiatriques, Hôpital Necker-Enfants Malades Paris; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, and Department of Paediatrics, Security Forces Hospital, Riyadh, Saudi Arabia; Génétique Epidémiologique et Structure des Populations Humaines, INSERM U535, Le Kremlin Bicêtre, France; Medical Research Council Center for Immune Regulation, The Medical School, University of Birmingham, Birmingham, United Kingdom; Department of Clinical Immunology, Addenbrookes Hospital National Health Service Trust, Cambridge; and Departments of Paediatrics and Pathology, National University Hospital of Singapore, Singapore
| |
Collapse
|
45
|
Reichenbach J, Rosenzweig S, Döffinger R, Dupuis S, Holland SM, Casanova JL. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2001; 1:503-11. [PMID: 11964733 DOI: 10.1097/00130832-200112000-00003] [Citation(s) in RCA: 74] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Primary immunodeficiency diseases comprise over 100 conditions, each associated with a variety of viral, bacterial, fungal and protozoan infections. M. tuberculosis and less virulent mycobacteria, such as bacille Calmette-Guérin vaccines and environmental non-tuberculous mycobacteria, may cause severe disease in patients with primary immunodeficiency diseases. However, no previous review has dealt with the issue of which primary immunodeficiency diseases predispose affected individuals to mycobacterial disease. This information is very useful, not only increasing our understanding of human immunity to mycobacteria, but also for the diagnostic investigation of patients with mycobacteriosis. We review here the medical literature on cases of mycobacterial disease in patients with primary immunodeficiency diseases.
Collapse
Affiliation(s)
- J Reichenbach
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Université René Descartes, Faculté de Médecine Necker Enfants Malades, Paris, France
| | | | | | | | | | | |
Collapse
|
46
|
Altare F, Casanova JL. IL-12 et IFN-γ : un axe clé de l’immunité anti-mycobactérienne chez l’homme. Med Sci (Paris) 2001. [DOI: 10.1051/medsci/200117111112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|